The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

This journal activity provides the clinician with essential terminology, guidelines, and process workflows to conduct rigorous and high-quality systematic review of the medical literature.

This session highlights five of the most clinically relevant abstracts within the Central Nervous System track of the 2022 ASTRO Annual Meeting scientific program.

This journal activity, Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial, provides practitioners with information on the side effects and efficacy associated with the use

This journal activity provides practitioners with the knowledge about standard techniques and doses for the treatment of endometrial cancer.

The session will empower attendees to critically evaluate clinical trials to best translate clinical trial findings to patient care.

Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies.

This journal activity provides practitioners with the knowledge in understanding whether radiotherapy when given with Cyclin-Dependent Kinase (CDK) 4/6 inhibitors is associated with a different toxicity profile than radiotherapy alone.

Covid-19 rapidly affected our lives and the life of our patients. Vaccination campaign started in 2021. At least four types of vaccines are widely used in the US (Pfizer, Moderna, Johnson and Johnson and Astra Zeneca).

The course consists of two debates. The first debate consists of two thoracic oncologists with one arguing for the use of surgery and one against the use of surgery for patients with stage III NSCLC.


Subscribe to RSS - CME only